E. Blind

Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment

Amy Egan, E. Blind, Kristina Dunder et al. · New England Journal of Medicine · 2014 · 485 citations · Full text

Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor

Asif Ali, P. T. Christie, I. V. Grigorieva et al. · Human Molecular Genetics · 2006 · 149 citations

Developmental Biology, Dna Binding, Gata3 Mutations +13

Two-Site Assay of Intact Parathyroid Hormone in the Investigation of Primary Hyperparathyroidism and Other Disorders of Calcium Metabolism Compared With a Midregion Assay*

E. Blind, H. Schmidt‐Gayk, Stephan Scharla et al. · The Journal of Clinical Endocrinology & Metabolism · 1988 · 121 citations

Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients.

Martin Pecherstorfer, Tobias Schilling, E. Blind et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 73 citations

Urology, Endocrine Disease, Medicine +15

Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.

Tobias Schilling, Martin Pecherstorfer, E. Blind et al. · The Journal of Clinical Endocrinology & Metabolism · 1993 · 70 citations

Urology, Parathyroid Hormone, Parathyroid Disease +9